Delayed hospital presentation in patients who have had acute myocardial infarction

Annals of Internal Medicine

Volumn 126, Issue 8, 1997, Pages 593-599

  Gurwitz, Jerry H ^a   McLaughlin, Thomas J ^b   Willison, Donald J ^c   Guadagnoli, Edward ^b   Hauptman, Paul J ^b   Gao, Xiaoming ^b   Soumerai, Stephen B ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0030934849     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-8-199704150-00001     Document Type: Article

References (38)

1. Turi ZG, Stone PH, Muller JE, Parker C, Rude RE, Raabe DE, et al. Implications for acute intervention related to time of hospital arrival in acute myocardial infarction. Am J Cardiol. 1986;58:203-9.
2. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FIT) Collaborative Group. Lancet. 1994;343:311-22.
3. Newby LK, Rutsch WR, Califf RM, Simoons ML, Aylward PE, Armstrong PW, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol. 1996; 27:1646-55.
4. Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy. A GISSI-generated study. GISSI - Avoidable Delay Study Group. Arch Intern Med. 1995;155:1481-8.
5. Maynard C, Weaver WD, Lambrew C, Bowlby LJ, Rogers WJ, Rubison RM. Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction). Participants in the National Registry of Myocardial Infarction. Am J Cardiol. 1995;76:548-52.
6. Goldberg RJ, Gurwitz J, Yarzebski J, Landon J, Gore JM, Alpert JS, et al. Patient delay and receipt of thrombolytic therapy among patients with acute myocardial infarction from a community-wide perspective. Am J Cardiol. 1992;70:421-5.
7. McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Borbas C, Guadagnoli E, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction in community hospitals: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996; 156:799-805.
8. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care. 1993;31:141-54.
9. Greenfield S, Sullivan L, Silliman RA, Dukes K, Kaplan SH. Principles and practice of case mix adjustment: applications to end-stage renal disease. Am J Kidney Dis. 1994;24:298-307.
10. SAS Institute. SAS/STAT User's Guide. Version 6. 4th ed, v 2. Cary, NC: SAS Institute; 1989.
11. Olin HS, Hackett TP. The denial of chest pain in 32 patients with acute myocardial infarction. JAMA. 1964;190:977-82.
12. Hackett TP, Cassem NH. Factors contributing to delay in responding to the signs and symptoms of acute myocardial infarction. Am J Cardiol. 1969;24: 651-8.
13. Yarzebski J, Goldberg RJ, Gore JM, Alpert JS. Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J. 1994;128:255-63.
14. Medalie JH, Goldbourt U. Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. Ann Intern Med. 1976;84:526-31.
15. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update from the Framingham study. N Engl J Med. 1984; 311:1144-7.
16. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med. 1995;122:96-102.
17. Maynard C, Althouse R, Olsufka M, Ritchie JL, Davis KB, Kennedy JW. Early versus late hospital arrival for acute myocardial infarction in the western Washington thrombolytic therapy trials. Am J Cardiol. 1989;63:1296-300.
18. Weaver WD, Litwin PE, Martin JS, Kudenchuk PJ, Maynard C, Eisenberg MS, et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group. J Am Coll Cardiol. 1991; 18:657-62.
19. Schmidt SB, Borsch MA. The prehospital phase of acute myocardial infarction in the era of thrombolysis. Am J Cardiol. 1990;65:1411-5.
20. Meischke H, Eisenberg MS, Larsen MP. Prehospital delay interval for patients who use emergency medical services: the effect of heart-related medical conditions and demographic variables. Ann Emerg Med. 1993;22: 1597-601.
21. Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ. Recent age-related trends in the use of thrombolytic therapy use in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction. Ann Intern Med. 1996;124:283-91.
22. Udvarhelyi IS, Gatsonis C, Epstein AM, Pashos CL, Newhouse JP, McNeil BJ. Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. JAMA. 1992;268:2530-6.
23. Maggloni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per io Studio della Sopprawivenza nell'Infarto Miocardio (GISSI-2). N Engl J Med. 1993;329:1442-8.
24. Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alpert JS. Recent trends in hospital mortality of acute myocardial infarction - the Worcester Heart Attack Study. Have improvements been realized for all age groups? Arch Intern Med. 1994;154:2202-8.
25. Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. N Engl J Med. 1993;329:247-56.
26. Dracup K, Moser DK, Eisenberg M, Meischke H, Alonzo AA, Braslow A. Causes of delay in seeking treatment for heart attack symptoms. Soc Sci Med. 1995;40:379-92.
27. Ell K, Haywood U, Sobel E, deGuzman M, Blumfield D, Ning JP. Acute chest pain in African Americans: factors in the delay in seeking emergency care. Am J Public Health. 1994;84:965-70.
28. Rowley JM, Mounser P, Harrison EA, Skene AM, Hampton JR. Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register. Br Heart J. 1992;67:255-62.
29. Rawles JM, Haites NE. Patient and general practitioner delays in acute myocardial infarction. Br Med J (Clin Res Ed). 1988;296:882-4.
30. Birkhead JS. Time delays in provision of thrombolytic treatment in six district hospitals. Joint Audit Committee of the British Cardiac Society and a Cardiology Committee of Royal College of Physicians of London. BMJ. 1992;305: 445-7.
31. Bleeker JK, Simoons ML, Erdman RA, Leenders CM, Kruyssen HA, Lamers LM, et al. Patient and doctor delay in acute myocardial infarction: a study in Rotterdam, the Netherlands. Br J Gen Pract. 1995;45:181-4.
32. Hungerbuhler P, Wietlisbach V, Rickenbach M, Vogt P. Evolution du traitment de l'infarctus du myocarde en Suisse de 1986 a 1990: les résultats d'une étude de population. [Developments in the treatment of myocardial infarction in Switzerland 1986-1990: results of a population survey.] Schweiz Med Wochenschr. 1992;122:1919-26.
33. Johnson JA, King KB. Influence of expectations about symptoms on delay in seeking treatment during a myocardial infarction. Am J Crit Care. 1995;4:29-35.
34. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992;268:1417-22.
35. Kereiakes DJ, Weaver WD, Anderson JL, Feldman T, Gibler B, Aufderheide T, et al. Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J. 1990;120:773-80.
36. National Heart Attack Coordinating Committee 60 Minutes to Treatment Working Group. Emergency Department: Rapid Identification and Treatment of Patients with Acute Myocardial Infarction. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute; 1993. NIH publication no. 93-3278.
37. Meischke H, Ho MT, Eisenberg MS, Schaeffer SM, Larsen MP. Reasons patients with chest pain delay or do not call 911. Ann Emerg Med. 1995;25: 193-7
38. Weaver WD. Time to thrombolytic therapy: factors affecting delay and their influence on outcome. J Am Coll Cardiol. 1995;25(7 Suppl):3S-9S.